Connecting asciminib tolerability to long-term treatment persistence. Comment on: "Favorable tolerability of asciminib versus ATP-competitive tyrosine kinase inhibitors in the ASC4FIRST study of newly diagnosed patients with chronic-phase chronic mye
Authors
- Chan Zhang
Institutions
- Dalian Medical University (CN)
Publication Details
- Journal
- Haematologica
- Published
- 2026-07-23
- DOI
- https://doi.org/10.3324/haematol.2026.301608
- Primary Topic
- Chronic Myeloid Leukemia Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00